Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Restorative effects of red onion (Allium cepa L.) juice on erectile function after-treatment with 5α-reductase inhibitor in rats

Abstract

Benign prostatic hyperplasia (BPH) is one of the most prevalent conditions among aged men. The use of 5α-reductase inhibitors (5-ARIs) to treat BPH was linked to erectile dysfunction (ED). Many medicinal plants and secondary metabolites are used in the management of ED. Onion (Allium cepa L.) is an economically affordable vegetable with vital phytochemicals and biological functions. The study aimed to identify the beneficial effects of onion juice on dutasteride (a 5-ARI)-induced ED. Rats were divided into two groups (n = 5 per group): control and dutasteride-treated rats (0.5 mg/kg/day). Dutasteride was administered in drinking water for 12 weeks. Experiments were performed at the end of the 12th week. In vivo erectile responses were measured before and after intracavernosal injection of onion. Relaxant responses to onion juice were examined in the corpus cavernosum (CC). Acetylcholine (ACh)-, electrical field stimulation (EFS)-, sodium nitroprusside (SNP)-induced relaxation responses in CC tissues were evaluated in the absence and presence of onion juice. Total intracavernosal pressure (ICP) and ICP/ mean arterial pressure were significantly reduced in dutasteride-treated rats (1881.14 ± 249.72 mmHg, P < 0.001;0.26 ± 0.03, P < 0.01) as compared to control rats (4542.60 ± 429.19 mmHg, 0.51 ± 0.05), which was normalized after the intracavernous administration of onion (3288.60 ± 185.45 mmHg, 0.58 ± 0.04). Onion markedly induced relaxant responses in control (72.5 ± 4.7) and dutasteride-treated (66.5 ± 2.7) groups after precontraction with phenylephrine. Relaxation responses to onion were partially inhibited after precontraction with KCl (32.5 ± 3.1, P < 0.001). The relaxant responses to ACh (14.9 ± 4.2, P < 0.01) were diminished in dutasteride-treated CC) compared to control CC (59.8 ± 3.4), which was enhanced after the incubation with onion (36.6 ± 4.8). There were no differences in relaxation response to SNP among all groups. However, relaxation response to SNP was reduced in dutasteride-treated CC at 1 μM (P < 0.05) and 10 μM dosages (P < 0.001), which was partially increased after the incubation with onion at 10 μM dosage (P < 0.01). The presence of onion did not change the reduction in EFS-caused relaxation in the dutasteride-treated group. The current data suggest that red onion juice has a restorative effect on erectile function and endothelium-dependent relaxation response following the treatment of dutasteride.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: In vivo intracavernosal effect of onion on the erectile response.
Fig. 2: Dose-response relaxation curves to onion in the CC.
Fig. 3: Dose-response relaxation curves in the absence or presence of onion.

References

  1. 1.

    Harbitz TB, Haugen OA. Histology of the prostate in elderly men. A study in an autopsy series. Acta Pathol Microbiol Scand A. 1972;80:756–68.

    CAS  PubMed  Google Scholar 

  2. 2.

    McVary KT. Clinical evaluation of benign prostatic hyperplasia. Rev Urol. 2003;5 Suppl 4:S3–11.

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    Alcaraz A, Carballido-Rodriguez J, Unda-Urzaiz M, Medina-Lopez R, Ruiz-Cerda JL, Rodriguez-Rubio F, et al. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment-the QUALIPROST study. Int Urol Nephrol. 2016;48:645–56.

    PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118–40.

    PubMed  Article  Google Scholar 

  5. 5.

    McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185:1793–803.

    PubMed  Article  Google Scholar 

  6. 6.

    Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89:2179–84.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Shigehara K, Miyagi T, Nakashima T, Izumi K, Kitagawa Y, Mizokami A, et al. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction. Aging Male. 2016;19:128–33.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Corona G, Tirabassi G, Santi D, Maseroli E, Gacci M, Dicuio M, et al. Sexual dysfunction in subjects treated with inhibitors of 5alpha-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis. Andrology. 2017;5:671–8.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Gupta AK, Carviel J, MacLeod MA, Shear N. Assessing finasteride-associated sexual dysfunction using the FAERS database. J Eur Acad Dermatol Venereol. 2017;31:1069–75.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Lee S, Lee YB, Choe SJ, Lee WS. Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. Acta Derm Venereol. 2019;99:12–17.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Sung HH, Yu J, Kang SJ, Chae MR, So I, Park JK, et al. Persistent erectile dysfunction after discontinuation of 5-alpha reductase inhibitor therapy in rats depending on the duration of treatment. World J Mens Health. 2019;37:240–8.

    PubMed  Article  Google Scholar 

  12. 12.

    Oztekin CV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, et al. Incomplete recovery of erectile function in rat after discontinuation of dual 5-alpha reductase inhibitor therapy. J Sex Med. 2012;9:1773–81.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Speakman MJ, Cornu JN, Gacci M, Gratzke C, Mamoulakis C, Herrmann TRW, et al. What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus. 2019;5:351–6.

    PubMed  Article  Google Scholar 

  14. 14.

    Song J, Lee SH, Kim H. Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial. Med (Baltim). 2019;98:e17848.

    Article  Google Scholar 

  15. 15.

    Fourcade RO, Theret N, Taieb C, Group BUS. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries. Bju Int. 2008;101:1111–8.

    PubMed  Article  Google Scholar 

  16. 16.

    Barnes PM, Bloom B, Nahin RL Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008;1-23.

  17. 17.

    Rho J, Seo CS, Park HS, Jeong HY, Moon OS, Seo YW, et al. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation. J Ethnopharmacol. 2020;255:112779.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Choi HM, Jung Y, Park J, Kim HL, Youn DH, Kang J, et al. Cinnamomi cortex (cinnamomum verum) suppresses testosterone-induced benign prostatic hyperplasia by regulating 5alpha-reductase. Sci Rep. 2016;6:31906.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Liu J, Fang T, Li M, Song Y, Li J, Xue Z, et al. Pao pereira extract attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5alpha-reductase. Sci Rep. 2019;9:19703.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Ooi SL, Pak SC. Serenoa repens for lower urinary tract symptoms/benign prostatic hyperplasia: current evidence and its clinical implications in naturopathic medicine. J Alter Complement Med. 2017;23:599–606.

    Article  Google Scholar 

  21. 21.

    Jena AK, Vasisht K, Sharma N, Kaur R, Dhingra MS, Karan M. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species. J Ethnopharmacol. 2016;190:33–45.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Guercio V, Galeone C, Turati F, La Vecchia C. Gastric cancer and allium vegetable intake: a critical review of the experimental and epidemiologic evidence. Nutr Cancer. 2014;66:757–73.

    PubMed  Article  Google Scholar 

  23. 23.

    Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Philos). 2015;8:181–9.

    CAS  Article  Google Scholar 

  24. 24.

    Kim SH, Jo SH, Kwon YI, Hwang JK. Effects of onion (Allium cepa L.) extract administration on intestinal alpha-glucosidases activities and spikes in postprandial blood glucose levels in SD rats model. Int J Mol Sci. 2011;12:3757–69.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Lee B, Jung JH, Kim HS. Assessment of red onion on antioxidant activity in rat. Food Chem Toxicol. 2012;50:3912–9.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Gorinstein S, Leontowicz H, Leontowicz M, Jastrzebski Z, Najman K, Tashma Z, et al. The influence of raw and processed garlic and onions on plasma classical and non-classical atherosclerosis indices: investigations in vitro and in vivo. Phytother Res. 2010;24:706–14.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Gennaro L, Leonardi C, Esposito F, Salucci M, Maiani G, Quaglia G, et al. Flavonoid and carbohydrate contents in Tropea red onions: effects of homelike peeling and storage. J Agric Food Chem. 2002;50:1904–10.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Gorinstein S, Leontowicz H, Leontowicz M, Namiesnik J, Najman K, Drzewiecki J, et al. Comparison of the main bioactive compounds and antioxidant activities in garlic and white and red onions after treatment protocols. J Agric Food Chem. 2008;56:4418–26.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Elberry AA, Mufti S, Al-Maghrabi J, Abdel Sattar E, Ghareib SA, Mosli HA, et al. Immunomodulatory effect of red onion (Allium cepa Linn) scale extract on experimentally induced atypical prostatic hyperplasia in Wistar rats. Mediators Inflamm. 2014;2014:640746.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  30. 30.

    Ma Z, Hung Nguyen T, Hoa Huynh T. Tien Do P, Huynh H. Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. J Endocrinol. 2004;181:493–507.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Khaleghi Ghadiri M, Gorji A. Natural remedies for impotence in medieval Persia. Int J Impot Res. 2004;16:80–83.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Malviya N, Jain S, Gupta VB, Vyas S. Management of drug induced sexual dysfunction in male rats by ethyl acetate fraction of onion. Acta Pol Pharm. 2013;70:317–22.

    PubMed  Google Scholar 

  33. 33.

    Allouh MZ, Daradka HM, Al Barbarawi MM, Mustafa AG. Fresh onion juice enhanced copulatory behavior in male rats with and without paroxetine-induced sexual dysfunction. Exp Biol Med (Maywood). 2014;239:177–82.

    Article  CAS  Google Scholar 

  34. 34.

    Lines TC, Ono M. FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A). Phytomedicine. 2006;13:236–9.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Chen KK, Chan JY, Chang LS, Chen MT, Chan SH. Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection. J Urol. 1992;147:1124–8.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Italiano G, Calabro A, Pagano F. A simplified in vitro preparation of the corpus cavernosum as a tool for investigating erectile pharmacology in the rat. Pharm Res. 1994;30:325–34.

    CAS  Article  Google Scholar 

  37. 37.

    Pinsky MR, Gur S, Tracey AJ, Harbin A, Hellstrom WJ. The effects of chronic 5-alpha-reductase inhibitor (dutasteride) treatment on rat erectile function. J Sex Med. 2011;8:3066–74.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Valle G, Carmignani M, Stanislao M, Michelini S, Volpe AR. Traditional medicine, corpus cavernosum and hydrogen sulphide. J Sex Med. 2011;8:631–2.

    PubMed  Article  Google Scholar 

  39. 39.

    Yilmaz-Oral D, Kaya-Sezginer E, Oztekin CV, Bayatli N, Lokman U, Gur S. Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model. Neurourol Urodyn. 2020;39:1087–97.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, et al. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol. 2010;30:1998–2004.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Modis K, Panopoulos P, et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA. 2012;109:9161–6.

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Ebeigbe AB, Aloamaka CP. Role of endothelium in magnesium-induced relaxation of rat aorta. Res Exp Med (Berl). 1987;187:25–31.

    CAS  Article  Google Scholar 

  43. 43.

    Naseri MK, Arabian M, Badavi M, Ahangarpour A. Vasorelaxant and hypotensive effects of Allium cepa peel hydroalcoholic extract in rat. Pak J Biol Sci. 2008;11:1569–75.

    PubMed  Article  Google Scholar 

  44. 44.

    Gasparotto Junior A, Dos Reis Piornedo R, Assreuy J, Da Silva-Santos JE. Nitric oxide and Kir6.1 potassium channel mediate isoquercitrin-induced endothelium-dependent and independent vasodilation in the mesenteric arterial bed of rats. Eur J Pharm. 2016;788:328–34.

    Article  CAS  Google Scholar 

  45. 45.

    Maeda Y, Aoki Y, Sekiguchi F, Matsunami M, Takahashi T, Nishikawa H, et al. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain. 2009;142:127–32.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Marques-da-Silva D, Samhan-Arias AK, Tiago T, Gutierrez-Merino C. L-type calcium channels and cytochrome b5 reductase are components of protein complexes tightly associated with lipid rafts microdomains of the neuronal plasma membrane. J Proteom. 2010;73:1502–10.

    CAS  Article  Google Scholar 

  47. 47.

    Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, et al. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol. 2008;53:391–9.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Gur S, Kadowitz PJ, Sikka SC, Peak TC, Hellstrom WJ. Overview of potential molecular targets for hydrogen sulfide: A new strategy for treating erectile dysfunction. Nitric Oxide. 2015;50:65–78.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Chen JH, Tsai SJ, Chen HI. Welsh onion (Allium fistulosum L.) extracts alter vascular responses in rat aortae. J Cardiovasc Pharm. 1999;33:515–20.

    CAS  Article  Google Scholar 

  50. 50.

    Gonzalez-Pena D, Angulo J, Vallejo S, Colina-Coca C, de Ancos B, Sanchez-Ferrer CF, et al. High-cholesterol diet enriched with onion affects endothelium-dependent relaxation and NADPH oxidase activity in mesenteric microvessels from Wistar rats. Nutr Metab (Lond). 2014;11:57.

    Article  CAS  Google Scholar 

  51. 51.

    Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 2006;24:75–84.

    CAS  PubMed  Article  Google Scholar 

  52. 52.

    Adefegha SA, Oyeleye SI, Dada FA, Olasehinde TA, Oboh G. Modulatory effect of quercetin and its glycosylated form on key enzymes and antioxidant status in rats penile tissue of paroxetine-induced erectile dysfunction. Biomed Pharmacother. 2018;107:1473–9.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Boydens C, Pauwels B, Vanden Daele L, Van, de Voorde J. Protective effect of resveratrol and quercetin on in vitro-induced diabetic mouse corpus cavernosum. Cardiovasc Diabetol. 2016;15:46.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  54. 54.

    Boydens C, Pauwels B, Decaluwe K, Brouckaert P, Van, de Voorde J. Relaxant and antioxidant capacity of the red wine polyphenols, resveratrol and quercetin, on isolated mice corpora cavernosa. J Sex Med. 2015;12:303–12.

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Slimestad R, Fossen T, Vagen IM. Onions: a source of unique dietary flavonoids. J Agric Food Chem. 2007;55:10067–80.

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Nakayama Y, Tanaka K, Hiramoto S, Yahata N, Inagawa Y, Nukui K, et al. Alleviation of the aging males’ symptoms by the intake of onion-extracts containing concentrated cysteine sulfoxides for 4 weeks—Randomized, double-blind, placebo-controlled, parallel-group comparative study. Japn Pharmacol Ther. 2017;45:595–608.

    CAS  Google Scholar 

  57. 57.

    Tsujimoto M, Agawa C, Ueda S, Yamane T, Kitayama H, Terao A, et al. Inhibitory effects of juices prepared from individual vegetables on CYP3A4 activity in recombinant CYP3A4 and LS180 cells. Biol Pharm Bull. 2017;40:1561–5.

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Andriole GL, Kirby R. Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol. 2003;44:82–88.

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Tayeb MT, Clark C, Haites NE, Sharp L, Murray GI, McLeod HL. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br J Cancer. 2003;88:928–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Serap Gur.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yilmaz-Oral, D., Onder, A., Kaya-Sezginer, E. et al. Restorative effects of red onion (Allium cepa L.) juice on erectile function after-treatment with 5α-reductase inhibitor in rats. Int J Impot Res (2021). https://doi.org/10.1038/s41443-021-00421-y

Download citation

Search

Quick links